Kawasaki disease in Hong Kong, 1994 to 2000
- PMID: 16219951
Kawasaki disease in Hong Kong, 1994 to 2000
Abstract
Objective: To describe the epidemiology, clinical characteristics, and management of Kawasaki disease in children in Hong Kong.
Design: Retrospective survey of medical records from July 1994 to June 1997, and prospective data collection from July 1997 to June 2000.
Setting: Hospitals with a paediatric unit in Hong Kong.
Patients: Patients diagnosed with Kawasaki disease between July 1994 and June 2000 in public hospitals in Hong Kong.
Main outcome measures: Incidence of Kawasaki disease and coronary artery aneurysm rates.
Results: A total of 696 cases of Kawasaki disease were reported. There were 435 (62.5%) boys and 261 (37.5%) girls giving a male to female ratio of 1.7:1. The age ranged from 1 month to 15 years 5 months with a median of 1.7 years. Infants (<1 year) constituted the largest group of patients (223, 32.0%) and overall, 638 (91.7%) were younger than 5 years. Skin rash, conjunctivitis, and oral signs were among the principal clinical features present in over 80% of cases. Prominent cervical lymph nodes larger than 1.5 cm were less commonly found (24%). Coronary artery aneurysms or ectasia were present in 15.7% (109/696), 8.5% (59/696), and 5.0% (35/696) of patients at 2, 4, and 8 weeks, respectively. The incidence of Kawasaki disease per 100,000 children under 5 years was significantly higher in the prospective study period than in the retrospective period (39 vs 26, P<0.001).
Conclusion: The incidence of Kawasaki disease is high in Hong Kong and is 39 per 100,000 children below 5 years of age. The coronary artery aneurysm prevalence is 5%. Intravenous gamma-globulin and high-dose aspirin is the mainstay of treatment.
Similar articles
-
Lack of association of cervical lymphadenopathy and coronary artery complications in Kawasaki disease.Pediatr Infect Dis J. 2006 Jun;25(6):521-5. doi: 10.1097/01.inf.0000215263.96289.1c. Pediatr Infect Dis J. 2006. PMID: 16732150
-
Epidemiological features of Kawasaki disease in Korea, 2006-2008.Pediatr Int. 2011 Feb;53(1):36-9. doi: 10.1111/j.1442-200X.2010.03178.x. Pediatr Int. 2011. PMID: 20534021
-
Epidemiological investigation of Kawasaki disease in Jilin province of China from 2000 to 2008.Cardiol Young. 2010 Aug;20(4):426-32. doi: 10.1017/S1047951110000375. Epub 2010 Apr 26. Cardiol Young. 2010. PMID: 20420740
-
Treatment of Kawasaki disease.Clin Pharm. 1990 Oct;9(10):755-62. Clin Pharm. 1990. PMID: 2242655 Review.
-
Kawasaki disease.Yonsei Med J. 2006 Dec 31;47(6):759-72. doi: 10.3349/ymj.2006.47.6.759. Yonsei Med J. 2006. PMID: 17191303 Free PMC article. Review.
Cited by
-
Coronary Artery Complications in Pediatric Patients with Kawasaki Disease: A 12-Year National Survey.Acta Cardiol Sin. 2013 Jul;29(4):357-65. Acta Cardiol Sin. 2013. PMID: 27122730 Free PMC article.
-
New biomarkers of Kawasaki disease identified by urine proteomic analysis.FEBS Open Bio. 2018 Dec 20;9(2):265-275. doi: 10.1002/2211-5463.12563. eCollection 2019 Feb. FEBS Open Bio. 2018. PMID: 30761252 Free PMC article.
-
Single-nucleotide polymorphism rs2290692 in the 3'UTR of ITPKC associated with susceptibility to Kawasaki disease in a Han Chinese population.Pediatr Cardiol. 2012 Oct;33(7):1046-53. doi: 10.1007/s00246-012-0223-x. Epub 2012 Feb 24. Pediatr Cardiol. 2012. PMID: 22361738
-
Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase.Ital J Pediatr. 2018 Aug 30;44(1):102. doi: 10.1186/s13052-018-0536-3. Ital J Pediatr. 2018. PMID: 30157897 Free PMC article. Review.
-
COVID-19 and Hyperinflammatory Syndrome in Children: Kawasaki Disease with Macrophage Activation Syndrome in Disguise?Cureus. 2020 Aug 1;12(8):e9515. doi: 10.7759/cureus.9515. Cureus. 2020. PMID: 32884871 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical